Johnson & Johnson Health Care Systems INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.0Mgeneral payments (2019-2025)

$0.00research payments (2019-2025)

1,207clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $18K

2020 $1,739

2021 $395K

2022 $266K

2023 $480K

2024 $435K

2025 $403K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Orthopaedic Surgery $290K

Plastic Surgery $202K

Plastic and Reconstructive Surgery $157K

Optometrist $135K

Internal Medicine $115K

Urology $107K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

Clinician	Location	Specialty	General payments (2019-2025)
Alice Chu	Clifton, NJ		$164,112.40
Walter Dearolf	Philadelphia, PA	Orthopaedic Surgery	$89,810.00
Mahmoud Khattab	Elk Grove, CA	Internal Medicine	$88,039.46
Daniel Durante	Jensen Beach, FL	Optometrist	$49,637.99
Tammi Allsep	Pasadena, TX	Optometrist	$41,684.50
Shitel Patel	Webster, TX	Plastic and Reconstructive Surgery	$38,905.96
Ramon Robles	Plano, TX	Plastic and Reconstructive Surgery	$36,646.88
Joseph Longo III	Scottsdale, AZ	Orthopaedic Trauma	$32,720.00
Richard Heekin	Jacksonville, FL	Adult Reconstructive Orthopaedic Surgery	$28,479.60
William Kim	Torrance, CA		$26,422.00

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.